•  41
    Race in health research: Considerations for researchers and research ethics committees
    with W. Van Staden, A. Nienaber, T. Rossouw, A. Turner, C. Filmalter, A. E. Mercier, J. G. Nel, B. Bapela, M. M. Beetge, R. Blumenthal, T. W. de Witt, A. G. Dlagnekova, C. Kotze, J. S. Mangwane, L. Napoles, R. Sommers, L. Sykes, W. B. van Zyl, M. Venter, A. Uys, and N. Warren
    South African Journal of Bioethics and Law 16 (1): 9-12. 2023.
    This article provides ethical guidance on using race in health research as a variable or in defining the study population. To this end, a plain, non-exhaustive checklist is provided for researchers and research ethics committees, preceded by a brief introduction on the need for justification when using race as a variable or in defining a study population, the problem of exoticism, that distinctions pertain between race, ethnicity and ancestry, the problematic naming of races, and that race does …Read more
  •  77
    Resource allocation during COVID-19: A focus on vulnerable populations
    with I. M. Viljoen, A. Dhai, and M. S. Pepper
    South African Journal of Bioethics and Law 13 (2): 83. 2020.
  •  350
    Expanding the Duty to Rescue to Climate Migration
    with David N. Hoffman, Anne Zimmerman, and Srajana Kaikini
    Voices in Bioethics 8. 2022.
    Photo by Jonathan Ford on Unsplash ABSTRACT Since 2008, an average of twenty million people per year have been displaced by weather events. Climate migration creates a special setting for a duty to rescue. A duty to rescue is a moral rather than legal duty and imposes on a bystander to take an active role in preventing serious harm to someone else. This paper analyzes the idea of expanding a duty to rescue to climate migration. We address who should have the duty and to whom the duty should exte…Read more
  •  4
    Oversight of biohacking when the stakes are high
    Voices in Bioethics 6. 2020.
  •  13
    Shifting Perceptions of CRISPR
    Voices in Bioethics 7. 2021.
    Photo by National Cancer Institute on Unsplash INTRODUCTION More than 20 cell and gene therapies are now available to safely minimize genetic diseases such as retinal dystrophy, some B-cell lymphomas, and B-cell lymphoblastic leukemia.[1] One such gene-editing tool is Clustered Regular Inter Spaced Palindromic Repeats and its associated proteins or CRISPR-Cas. Jennifer Doudna and Emmanuelle Charpentier described CRISPR’s potential as an accurate genome editing tool in 2012. The FDA approved the …Read more
  •  7
    Environmental and economical ethics collide
    Voices in Bioethics 6. 2020.
    In January 2020, during China’s COVID-19 outbreak, the NASA Earth Observatory captured aerial images indicating significantly lower emissions of nitrogen dioxide, a major air pollutant, across China’s mainland.[1] Scientists across the globe have reported preliminary empirical data that amid shelter-in-place directives and the shutting down of large-scale economic activity, the environment is flourishing. Abnormal sightings of wild animals roaming freely in deserted cities have been widely repor…Read more
  •  10
    Non-COVID-19 Patients Left out in the Cold
    Voices in Bioethics 6. 2020.